Skip to main content
Clinical Trials/IRCT20221109056455N1
IRCT20221109056455N1
Recruiting
Phase 3

A prospective randomized controlled study comparing 0.75% hyperbaric ropivacaine with 0.5% hyperbaric bupivacaine in spinal anesthesia for elective caesarean delivery

Tata Main Hospital, Jamshedpur0 sites98 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Tata Main Hospital, Jamshedpur
Enrollment
98
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Tata Main Hospital, Jamshedpur

Eligibility Criteria

Inclusion Criteria

  • ASA physical status 1 and 2
  • Pregnant adults for elective caesarean section

Exclusion Criteria

  • Allergy to Ropivacaine or Bupivacaine
  • Infection at the site for spinal anaesthesia
  • Patient with evidence of foetal distress
  • Short stature (150 cm)
  • Tall stature (\>180 cm)
  • Obesity(BMI\>30\)
  • Patient with an obstetrical complication (multiple gestations, bleeding, gestational hypertensive diseases)
  • Psychiatric or seizure disorder
  • Bleeding disorder
  • Cardiac disease

Outcomes

Primary Outcomes

Not specified

Similar Trials